척추 임플란트 및 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 기술별, 수술 유형별, 시술 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Spinal Implants And Devices Market Summary

The global spinal implants and devices market size was estimated at USD 13.91 billion in 2024 and is projected to reach USD 23.13 billion by 2033, growing at a CAGR of 6.0% from 2025 to 2033. The spinal implants and devices market is propelled by a rising burden of spinal disorders, rapid technological advancements improving surgical outcomes, and strategic expansion efforts into high-growth emerging regions.

Market players leveraging innovation and expanding their geographical footprint are well-positioned to capitalize on the growing demand for advanced spinal care solutions.According to WHO estimates, in April 2024, there are approximately 15.4 million individuals diagnosed/suffering from spinal cord injuries across the globe in 2021. The compression of the spinal nerve or damage results in injury to the external side of the vertebral column.

The rising prevalence of spinal disorders, including degenerative disc diseases, spinal stenosis, and vertebral fractures, is a primary driver of the spinal implants and devices market. An aging global population, coupled with lifestyle-related factors such as poor posture, obesity, and sedentary habits, has led to a surge in spinal ailments requiring surgical intervention. This growing patient pool is driving demand for a wide range of spinal implants, including fusion devices, non-fusion implants, and motion-preserving technologies to improve mobility and reduce chronic pain.In April 2025, according to Medscape, the global prevalence of low back pain (LBP) was estimated at 619 million in 2020 and is projected to rise to 843 million by 2050. Between 1990 and 2020, age-standardized prevalence and years lived with disability (YLDs) for LBP decreased by approximately 10%. In 2020, LBP accounted for 832 YLDs per 100,000 population worldwide.

Technological advancements in spinal implants and surgical techniques are significantly boosting market growth. Innovations such as 3D-printed patient-specific implants, minimally invasive surgical approaches, and the integration of navigation and robotic-assisted systems are enhancing surgical precision and outcomes. These advancements are reducing operative time, lowering complication rates, and facilitating faster patient recovery, making them increasingly preferred by both healthcare providers and patients. In November 2024, Carlsmed introduced a digital production line to improve the delivery timeline of its aprevo personalized spinal fusion implants. The new process is designed to reduce lead times to under ten days, supporting hospitals with shorter surgical scheduling windows.

Expanding healthcare infrastructure in emerging economies, coupled with rising investments from global medical device manufacturers, is driving geographical expansion of spinal implants and devices. Companies increasingly focus on underserved regions in Asia Pacific, Latin America, and the Middle East to tap into unmet clinical needs. Efforts to localize manufacturing, establish distribution networks, and provide surgeon training programs are making advanced spinal treatments more accessible and affordable in these regions, thereby accelerating market penetration. In April 2025, Spinal Simplicity expanded the commercial availability of its Minuteman G5 minimally invasive spinal implant to the UAE, marking a strategic geographic expansion to strengthen its global presence in the spinal implants and devices market.

Global Spinal Implants And Devices Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global spinal implants and devices market report based on product, technology, surgery type, procedure type, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Spinal Fusion Devices
  • Thoracic & Lumbar Fusion Devices
  • Cervical Fusion Devices
• Spinal Biologics
  • Allografts
  • Xenografts
  • DBM
  • BMP
  • Synthetic Bone Grafts
• Vertebral Compression Fracture Treatment Devices
• Non-fusion Devices
• Spinal Bone Growth Stimulators
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Spinal Fusion and Fixation Technologies
• Vertebral Compression Fracture Treatment
• Vertebroplasty
  • Kyphoplasty/Vertebral Augmentation
  • Motion Preservation Technologies
• Surgery Type Outlook (Revenue, USD Million, 2021 - 2033)
• Open Surgery
• Minimally Invasive Surgery
• Procedure Type Outlook (Revenue USD Million, 2021 - 2033)
• Discectomy
• Laminotomy
• Foraminotomy
• Corpectomy
• Facetectomy
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Technology outlook
  • 2.2.3. Surgery Type outlook
  • 2.2.4. Procedure type outlook
• 2.3. Competitive Insights

Chapter 3. Global Spinal Implants and Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Spinal Implants and Devices: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Landscape
• 3.5. Case Study Analysis

Chapter 4. Global Spinal Implants and Devices Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Spinal Implants and Devices Market, by Product, 2021 to 2033
• 4.5. Spinal Fusion devices
  • 4.5.1. Spinal fusion devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.2. Thoracic & Lumbar Fusion Devices
    • 4.5.2.1. Thoracic & lumbar fusion devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.3. Cervical Fusion Devices
    • 4.5.3.1. Cervical fusion devices market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Spinal biologics
  • 4.6.1. Spinal biologics market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.2. Allografts
    • 4.6.2.1. Allografts market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.3. Xenografts
    • 4.6.3.1. Xenografts market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.4. DBM
    • 4.6.4.1. DBM market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.5. BMP
    • 4.6.5.1. BMP market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.6. Synthetic Bone Grafts
    • 4.6.6.1. Synthetic bone grafts market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. Vertebral compression fracture treatment devices
  • 4.7.1. Vertebral compression fracture treatment devices market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.8. Non-fusion devices
  • 4.8.1. Non-fusion devices market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.9. Spinal bone growth stimulators
  • 4.9.1. Spinal bone growth stimulators market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Spinal Implants and Devices Market Segment Analysis, By Technology, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Technology Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Spinal Implants and Devices Market, by Technology, 2021 to 2033
• 5.5. Spinal Fusion and Fixation Technologies
  • 5.5.1. Spinal fusion and fixation technologies market estimates and forecasts, 2021 to 2033 (USD million)
• 5.6. Vertebral Compression Fracture Treatment
  • 5.6.1. Vertebral compression fracture treatment market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6.2. Vertebroplasty
    • 5.6.2.1. Vertebroplasty market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6.3. Kyphoplasty/Vertebral Augmentation
    • 5.6.3.1. Kyphoplasty/vertebral augmentation market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Motion Preservation Technologies
  • 5.7.1. Motion preservation technologies market estimates and forecasts, 2021 to 2033 (USD million)

Chapter 6. Global Spinal Implants and Devices Market Segment Analysis, By Surgery Type, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. Surgery Type Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Spinal Implants and Devices Market, by Surgery Type, 2021 to 2033
• 6.5. Open Surgery
  • 6.5.1. Open surgery market estimates and forecasts, 2021 to 2033 (USD million)
• 6.6. Minimally Invasive Surgery
  • 6.6.1. Minimally invasive surgery market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Global Spinal Implants and Devices Market Segment Analysis, By Procedure Type, 2021 - 2033 (USD Million)

• 7.1. Definition and Scope
• 7.2. Procedure Type Market Share Analysis, 2024 & 2033
• 7.3. Segment Dashboard
• 7.4. Global Spinal Implants and Devices Market, by Procedure Type, 2021 to 2033
• 7.5. Discectomy
  • 7.5.1. Discectomy market estimates and forecasts, 2021 to 2033 (USD million)
• 7.6. Laminotomy
  • 7.6.1. Laminotomy market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.7. Foraminotomy
  • 7.7.1. Foraminotomy market estimates and forecasts, 2021 to 2033 (USD million)
• 7.8. Corpectomy
  • 7.8.1. Corpectomy market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.9. Facetectomy
  • 7.9.1. Facetectomy market estimates and forecasts, 2021 to 2033 (USD million)

Chapter 8. Spinal Implants and Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

• 8.1. Regional Market Share Analysis, 2024 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Regional Market Snapshot
• 8.4. Spinal Implants and Devices Market Share by Region, 2024 & 2033:
• 8.5. North America
  • 8.5.1. North America spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Scenario
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. U.S. spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Scenario
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Canada spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Scenario
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Mexico spinal implants and devices market, 2021 - 2033 (USD Million)
• 8.6. Europe
  • 8.6.1. Europe spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.6.2. UK
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Scenario
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. UK spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.6.3. Germany
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Scenario
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Germany spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.6.4. France
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Scenario
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. France spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Scenario
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Italy spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Scenario
    • 8.6.6.3. Competitive Scenario
    • 8.6.6.4. Spain spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.6.7. Norway
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Regulatory Scenario
    • 8.6.7.3. Competitive Scenario
    • 8.6.7.4. Norway spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1. Key Country Dynamics
    • 8.6.8.2. Regulatory Scenario
    • 8.6.8.3. Competitive Scenario
    • 8.6.8.4. Sweden spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.6.9. Denmark
    • 8.6.9.1. Key Country Dynamics
    • 8.6.9.2. Regulatory Scenario
    • 8.6.9.3. Competitive Scenario
    • 8.6.9.4. Denmark spinal implants and devices market, 2021 - 2033 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key Country Dynamics
    • 8.7.1.2. Regulatory Scenario
    • 8.7.1.3. Competitive Scenario
    • 8.7.1.4. Japan spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Scenario
    • 8.7.2.3. Competitive Scenario
    • 8.7.2.4. China spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Scenario
    • 8.7.3.3. Competitive Scenario
    • 8.7.3.4. India spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Regulatory Scenario
    • 8.7.4.3. Competitive Scenario
    • 8.7.4.4. Australia spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Regulatory Scenario
    • 8.7.5.3. Competitive Scenario
    • 8.7.5.4. South Korea spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Regulatory Scenario
    • 8.7.6.3. Competitive Scenario
    • 8.7.6.4. Thailand spinal implants and devices market, 2021 - 2033 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key Country Dynamics
    • 8.8.1.2. Regulatory Scenario
    • 8.8.1.3. Competitive Scenario
    • 8.8.1.4. Brazil spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Scenario
    • 8.8.2.3. Competitive Scenario
    • 8.8.2.4. Argentina spinal implants and devices market, 2021 - 2033 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key Country Dynamics
    • 8.9.1.2. Regulatory Scenario
    • 8.9.1.3. Competitive Scenario
    • 8.9.1.4. South Africa spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key Country Dynamics
    • 8.9.2.2. Regulatory Scenario
    • 8.9.2.3. Competitive Scenario
    • 8.9.2.4. Saudi Arabia spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key Country Dynamics
    • 8.9.3.2. Regulatory Scenario
    • 8.9.3.3. Competitive Scenario
    • 8.9.3.4. UAE spinal implants and devices market, 2021 - 2033 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key Country Dynamics
    • 8.9.4.2. Regulatory Scenario
    • 8.9.4.3. Competitive Scenario
    • 8.9.4.4. Kuwait spinal implants and devices market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Profiles
  • 9.3.1. Medtronic
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. Johnson & Johnson
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. VB Spine, LLC
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. NuVasive
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Zimmer Biomet
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Globus Medical Inc.
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Alphatec Spine, Inc.
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Orthofix Holdings, Inc.
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. RTI Surgical Holdings
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Ulrich GmbH & Co.
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Braun Melsungen AG
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Seaspine Holdings Corporation
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives